IP Library Granted Patent US 10,765,111
Granted Patent B1
US 10,765,111 · App. 14/638,881 · Granted Sep 8, 2020

Cryosolutions and uses thereof

Inventor: Claudia Zylberberg (Delray Beach, FL)
Assignee: Akron Biotechnology, LLC
A01N1/0221
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,765,111
App. No.
14/638,881
Granted
Sep 8, 2020
Kind
B1
Abstract

Compositions for maintaining cellular integrity especially in cases of cryopreservation and multiple freeze/thawing cycles are provided. In addition, the compositions can be used in various media for a variety of applications.

Claims (11)

1. A composition for cryopreservation consisting of: polyethylene glycol (PEG), a saccharide, and an organic amphoteric agent, wherein the polyethylene glycol is present in the composition from 0.001% to 20% v/v, the saccharide is present in the composition from 0.1 μg/ml to 1 mg/ml and the organic amphoteric agent is present in the composition from 0.1% to 20% v/v, wherein:

said organic amphoteric agent is ectoin and/or hydroxyectoin;

said saccharide is trehalose and/or dextran-40;

said composition being added to a biological medium.

2. The composition of claim 1 , wherein the composition consists of from 0.1 μg/ml to 0.9 mg/ml of trehalose and/or dextran-40, from 0.1% to 20% v/v ectoin and/or hydroxyectoin and from 0.001% to 20% v/v of PEG.

3. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 800 μg/ml of trehalose.

4. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 700 μg/ml of trehalose.

5. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 500 μg/ml of trehalose.

6. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 250 μg/ml of trehalose.

7. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 100 μg/ml of trehalose.

8. The composition of claim 1 , wherein the composition comprises from 0.1 μg/ml to 50 μg/ml of trehalose.

Assignments (3)
CHANGE OF NAME Recorded May 16, 2025
From: AKRON BIOTECHNOLOGY, LLC
To: AKRON BIOPRODUCTS LLC
Reel/Frame 071298/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2016
From: ZYLBERBERG, CLAUDIA
To: AKRON BIOTECHNOLOGY, LLC
Reel/Frame 038208/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2016
From: ZYLBERBERG, CLAUDIA
To: AKRON BIOTECHNOLOGY, LLC
Reel/Frame 037862/0777 →
Continuity (1)
Provisional Application 61948338 · Mar 5, 2014